Cargando…
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD
BACKGROUND: Current evidence demonstrates that positive family history and several alterations in lipid metabolism are all important risk factors for coronary artery disease (CAD). All lipid abnormalities themselves have genetic determinants. Thus, objective of this study was to determine whether 6...
Autores principales: | Baroni, Marco G, Berni, Andrea, Romeo, Stefano, Arca, Marcello, Tesorio, Tullio, Sorropago, Giovanni, Di Mario, Umberto, Galton, David J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201027/ https://www.ncbi.nlm.nih.gov/pubmed/12964943 http://dx.doi.org/10.1186/1471-2350-4-8 |
Ejemplares similares
-
Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG
por: Eifert, Sandra, et al.
Publicado: (2009) -
Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins
por: Wang, Liyun, et al.
Publicado: (2014) -
CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration
por: Wang, Ya-Feng, et al.
Publicado: (2015) -
Is apoCIII-Lowering A Double-Edged Sword?
por: Tang, Xiangming, et al.
Publicado: (2022) -
Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels
por: Pirim, Dilek, et al.
Publicado: (2020)